The Ventana PD-L1 assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy.
Read More
The partnership will focus on analysis of the circulating proteome of advanced pancreatic cancer patients, using the Biodesix Diagnostic Cortex machine-learning platform.
Read More
Multigene panels would deliver greater value if patients with actionable genetic mutations consistently received guided treatments.
Read More
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreThe new genomic test is Veracyte’s first commercial product since the company signed a strategic collaboration with Johnson & Johnson Innovation.
Read More